Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cytopenia × IDO-1 inhibitor LY3381916 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Cytopenia 1

Interventions

ON 01910 2 epacadostat 1 Therapeutics 1 IDO-1 inhibitor LY3381916 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01822691 2016-01-18

Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed

15 enrolled 8 charts

Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡